Author
TransPharm Preclinical Solutions
Post
Imaging Infections
TransPharm Preclinical Solutions performs efficacy testing of novel therapeutics against a wide variety of infections in mice and rats. Historically…
Read more
Post
Common Antibacterial Agent Contributes to Antibiotic Resistance
Stores are stocked with items promising to kill bacteria, and many consumers purchase those products in an attempt to protect themselves from…
Read more
Post
Jackson is our Valentine
February 14th is all about love and we sure do love our town of Jackson, Michigan. In fact, on this day 126 years ago, Jackson officially became a…
Read more
Post
IACUC Approves Intratracheal Administration
TransPharm’s Institutional Animal Care and Use Committee (IACUC) recently approved intratracheal (IT) administration as a new route of inoculating…
Read more
Post
A “Two-Hit” Model of Sepsis
TransPharm recently validated a "two-hit" model of sepsis in which mice undergo cecal ligation and puncture (CLP) followed by intranasal instillation…
Read more
Post
AAALAC Accreditation Renewed
It's official! Based on a site visit back in May, AAALAC International has renewed our full accreditation.
Read more
Post
Fall 2018 Newsletter
TransPharm hit a major milestone in September! We have now performed over one thousand preclinical studies since opening in 2008. The team will be…
Read more
Post
Cease and Persist?
After a bacterial infection is established, a small percentage of the bacteria slow their metabolism in response to environmental stressors. This…
Read more
Post
Biofilms: Skimming the Surface
A biofilm is a thin layer of microorganisms that have adhered to a surface and formed a complex, multicellular, three-dimensional structure. The…
Read more
Post
Human-Derived Antibody against S. aureus α-Hemolysin
Mechanism of Action and In Vivo Efficacy of a Human-Derived Antibody against Staphylococcus aureus α-Hemolysin
Pfizer
Read more